0001209191-16-095327.txt : 20160203 0001209191-16-095327.hdr.sgml : 20160203 20160203163905 ACCESSION NUMBER: 0001209191-16-095327 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160201 FILED AS OF DATE: 20160203 DATE AS OF CHANGE: 20160203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sheena Jonathan CENTRAL INDEX KEY: 0001646649 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 161385350 MAIL ADDRESS: STREET 1: C/O NATERA, INC. STREET 2: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-01 0 0001604821 Natera, Inc. NTRA 0001646649 Sheena Jonathan C/O NATERA, INC. 201 INDUSTRIAL ROAD, SUITE 410 SAN CARLOS CA 94070 1 1 0 0 Chief Technology Officer Common Stock 2016-02-01 4 M 0 3000 0.00 A 625551 D Common Stock 2016-02-01 4 S 0 3000 8.0286 D 622551 D Common Stock 2016-02-01 4 S 0 7000 8.0244 D 615551 D Stock Option (right to buy) 1.141 2016-02-01 4 M 0 3000 0.00 D 2022-09-20 Common Stock 3000 85249 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The reported price in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $7.88 to $8.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). The reported price in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $7.83 to $8.29 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3). The option shares are fully vested and may be exercised at any time. /s/ Meaghan S. Nelson, attorney-in-fact 2016-02-03